Plasma ADAMTS-13 levels and the risk of myocardial infarction: an individual patient data meta-analysis-Reference-Cited by-同舟云学术

Plasma ADAMTS-13 levels and the risk of myocardial infarction: an individual patient data meta-analysis

Published:2015-07-14 Issue:8 Volume:13 Page:1396-1404
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Maino A.¹²,Siegerink B.¹³⁴,Lotta L. A.²,Crawley J. T. B.⁵,le Cessie S.¹⁶,Leebeek F. W. G.⁷,Lane D. A.⁵,Lowe G. D. O.⁸,Peyvandi F.²,Rosendaal F. R.¹³⁹

Affiliation:

1. Department of Clinical Epidemiology; Leiden University Medical Center; Leiden the Netherlands

2. A. Bianchi Bonomi Hemophilia and Thrombosis Center; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano; Università degli Studi di Milano; Milan Italy

3. Einthoven Laboratory for Experimental Vascular Medicine; Leiden University Medical Center; Leiden the Netherlands

4. Center for Stroke Research; Charité-Universitätsmedizin; Berlin Germany

5. Centre for Haematology; Faculty of Medicine; Imperial College London; London UK

6. Department of Medical Statistics and Bioinformatics; Leiden University Medical Center; Leiden the Netherlands

7. Department of Hematology; Erasmus University Medical Center; Rotterdam the Netherlands

8. Institute of Cardiovascular and Medical Sciences; University of Glasgow; Glasgow UK

9. Department of Thrombosis and Hemostasis; Leiden University Medical Center; Leiden the Netherlands

Funder

British Heart Foundation

Netherlands Heart Foundation

Prevention Fund, The Netherlands

NIHR Biomedical Research Centre Funding Scheme

Translational Research Fund of the Erasmus MC

Italian Ministry of University and Research

Fondazione Fiera di Milano

Research Foundation Flanders

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13032/fullpdf

Reference35 articles.

1. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura;Zheng;J Biol Chem,2001

2. von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura;Sadler;Blood,2008

3. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura;Levy;Nature,2001

4. Hemostatic factors and risk of coronary heart disease in general populations: new prospective study and updated meta-analyses;Willeit;PLoS ONE,2013

5. Variation in the von Willebrand factor gene is associated with von Willebrand factor levels and with the risk for cardiovascular disease;Schie;Blood,2011

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Highs and Lows of ADAMTS13 Activity;Journal of Clinical Medicine;2024-08-30

2. The Significance of Endothelial Dysfunction in Long COVID-19 for the Possible Future Pandemic of Chronic Kidney Disease and Cardiovascular Disease;Biomolecules;2024-08-08

3. Relationship Between Intraluminal Thrombus Volume and Circulating ADAMTS-13 Activity in Abdominal Aortic Aneurysms;EJVES Vascular Forum;2024-07

4. ADAMTS13 in pediatric sepsis: a prognostic biomarker with potential therapeutic implications;Egyptian Pediatric Association Gazette;2023-12-20

5. Impact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolism;Journal of Thrombosis and Haemostasis;2023-05